Ads
related to: treating leukemia with stem cells
Search results
Results From The WOW.Com Content Network
Hematopoietic stem cell transplantation. Hematopoietic stem-cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood, in order to replicate inside a patient and produce additional normal blood cells. [1][2][3][4][5][6] HSCT may be ...
Leukemia (also spelled leukaemia; pronounced / luːˈkiːmiːə / [1] loo-KEE-mee-ə) is a group of blood cancers that usually begin in the bone marrow and produce high numbers of abnormal blood cells. [9] These blood cells are not fully developed and are called blasts or leukemia cells. [2]
Acquired pure red cell aplasia. Myeloproliferative disorders. Polycythemia vera. Essential thrombocytosis. Myelofibrosis. Metabolic disorders. Amyloidoses. Amyloid light chain (AL) amyloidosis. Environmentally-induced diseases.
The end goal, Caldwell said, is to "dramatically expand" the pool of bone marrow stem cells from deceased organ donors to help fight cancer. "Leukemia is a treatable cancer if you are able to find ...
A Flint woman is believed to be the first in the world with leukemia to successfully undergo a transplant using stem cells from the bone marrow of a deceased donor — a medical advance that could ...
For over 90 years, hematopoietic stem cell transplantation (HSCT) has been used to treat people with conditions such as leukemia and lymphoma; this is the only widely practiced form of stem-cell therapy.